In the last 12 months, insiders at Dogwood Therapeutics, Inc. ($DWTX) filed 39 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
Dogwood Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- CK Life Sciences Intl (Holdings) Inc (Other) — 1 transaction totaling $1,993
- Burch Richard Alan (Not found) — 1 transaction totaling $0
- Pridgen William (Not found) — 1 transaction totaling $0
- Gendreau Roger Michael (CHIEF MEDICAL OFFICER) — 4 transactions totaling $0
- Walsh Angela (Chief Financial Officer) — 3 transactions totaling $0
View all SEC Filings for Dogwood Therapeutics, Inc. (DWTX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | Grosswald Ralph | SVP OF OPERATIONS | A | Stock Option (right to buy) | 82500 | $0.00 | 82,500.0000 | 1,919,433 | 9999.99% | 4.30% |
| March 5, 2026 | Walsh Angela | Chief Financial Officer | A | Stock Option (right to buy) | 82500 | $0.00 | 82,500.0000 | 1,919,433 | 9999.99% | 4.30% |
| March 5, 2026 | Gendreau Roger Michael | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 82500 | $0.00 | 82,500.0000 | 1,919,433 | 9999.99% | 4.30% |
| March 5, 2026 | Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 330000 | $0.00 | 330,000.0000 | 1,919,433 | 9999.99% | 17.19% |
| Dec. 4, 2025 | Walsh Angela | Chief Financial Officer | A | Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 1,919,433 | 9999.99% | 7.81% |
| Dec. 4, 2025 | Gendreau Roger Michael | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 1,919,433 | 9999.99% | 7.81% |
| Dec. 4, 2025 | Grosswald Ralph | SVP OF OPERATIONS | A | Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 1,919,433 | 9999.99% | 7.81% |
| Dec. 4, 2025 | Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 460000 | $0.00 | 460,000.0000 | 1,919,433 | 9999.99% | 23.97% |
| Nov. 21, 2025 | Sealbond Ltd | Other | C | Common Stock | 21610950 | $0.00 | 24,664,971.0000 | 1,919,433 | 707.62% | 100.00% |
| Nov. 21, 2025 | Sealbond Ltd | Other | C | Common Stock | 2842638 | $0.00 | 24,664,971.0000 | 1,919,433 | 13.03% | 100.00% |
| Nov. 21, 2025 | Sealbond Ltd | Other | C | Series A Preferred Stock | 2161 | $0.00 | 0.0000 | 1,919,433 | 100.00% | 0.11% |
| Nov. 21, 2025 | Sealbond Ltd | Other | C | Series A-1 Preferred Stock | 284 | $0.00 | 0.0000 | 1,919,433 | 100.00% | 0.01% |
| June 27, 2025 | Gendreau Roger Michael | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 12075 | $0.00 | 12,075.0000 | 1,441,535 | 9999.99% | 0.84% |
| June 27, 2025 | Whitley Richard James | Not found | A | Stock Option (right to buy) | 2362 | $0.00 | 2,362.0000 | 1,441,535 | 9999.99% | 0.16% |
| June 27, 2025 | Grosswald Ralph | SVP OF OPERATIONS | A | Stock Option (right to buy) | 12075 | $0.00 | 12,075.0000 | 1,441,535 | 9999.99% | 0.84% |
| June 27, 2025 | Thomas John C | Not found | A | Stock Option (right to buy) | 2362 | $0.00 | 2,362.0000 | 1,441,535 | 9999.99% | 0.16% |
| June 27, 2025 | Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 1,441,535 | 9999.99% | 2.77% |
| June 27, 2025 | Keefer David R | Not found | A | Stock Option (right to buy) | 2362 | $0.00 | 2,362.0000 | 1,441,535 | 9999.99% | 0.16% |
| June 27, 2025 | Walsh Angela | Chief Financial Officer | A | Stock Option (right to buy) | 12075 | $0.00 | 12,075.0000 | 1,441,535 | 9999.99% | 0.84% |
| June 27, 2025 | De La Rosa Abel | Not found | A | Stock Option (right to buy) | 2362 | $0.00 | 2,362.0000 | 1,441,535 | 9999.99% | 0.16% |
| June 18, 2025 | Whitley Richard James | Not found | A | Stock Option (right to buy) | 210 | $0.00 | 210.0000 | 1,441,535 | 9999.99% | 0.01% |
| June 18, 2025 | De La Rosa Abel | Not found | A | Stock Option (right to buy) | 210 | $0.00 | 420.0000 | 1,441,535 | 100.00% | 0.01% |
| June 18, 2025 | De La Rosa Abel | Not found | A | Stock Option (right to buy) | 210 | $0.00 | 210.0000 | 1,441,535 | 9999.99% | 0.01% |
| June 18, 2025 | Thomas John C | Not found | A | Stock Option (right to buy) | 210 | $0.00 | 420.0000 | 1,441,535 | 100.00% | 0.01% |
| June 18, 2025 | Thomas John C | Not found | A | Stock Option (right to buy) | 210 | $0.00 | 210.0000 | 1,441,535 | 9999.99% | 0.01% |
| June 18, 2025 | Keefer David R | Not found | A | Stock Option (right to buy) | 210 | $0.00 | 420.0000 | 1,441,535 | 100.00% | 0.01% |
| June 18, 2025 | Keefer David R | Not found | A | Stock Option (right to buy) | 210 | $0.00 | 210.0000 | 1,441,535 | 9999.99% | 0.01% |
| June 18, 2025 | Whitley Richard James | Not found | A | Stock Option (right to buy) | 210 | $0.00 | 420.0000 | 1,441,535 | 100.00% | 0.01% |
| March 12, 2025 | CK Life Sciences Intl (Holdings) Inc | Other | A | Series A-1 Preferred Stock | 284 | $7.01 | 284.2638 | 1,027,788 | 9999.99% | 0.03% |
| Feb. 26, 2024 | Keefer David R | Not found | A | Stock Option (right to buy) | 4709 | $0.00 | 4,709.0000 | 751,071 | 9999.99% | 0.63% |
| Feb. 26, 2024 | Pridgen William | Not found | A | Stock Option (right to buy) | 2917 | $0.00 | 2,917.0000 | 751,071 | 9999.99% | 0.39% |
| Feb. 26, 2024 | Burch Richard Alan | Not found | A | Stock Option (right to buy) | 2917 | $0.00 | 2,917.0000 | 751,071 | 9999.99% | 0.39% |
| Feb. 26, 2024 | De La Rosa Abel | Not found | A | Stock Option (right to buy) | 3959 | $0.00 | 3,959.0000 | 751,071 | 9999.99% | 0.53% |
| Feb. 26, 2024 | Walsh Angela | SVP OF FINANCE | A | Stock Option (right to buy) | 63618 | $0.00 | 63,618.0000 | 751,071 | 9999.99% | 8.47% |
| Feb. 26, 2024 | Grosswald Ralph | SVP OF OPERATIONS | A | Stock Option (right to buy) | 62568 | $0.00 | 62,568.0000 | 751,071 | 9999.99% | 8.33% |
| Feb. 26, 2024 | Gendreau Roger Michael | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 88085 | $0.00 | 88,085.0000 | 751,071 | 9999.99% | 11.73% |
| Feb. 26, 2024 | Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | A | Stock Option (right to buy) | 138835 | $0.00 | 138,835.0000 | 751,071 | 9999.99% | 18.49% |
| Feb. 26, 2024 | Whitley Richard James | Not found | A | Stock Option (right to buy) | 4000 | $0.00 | 4,000.0000 | 751,071 | 9999.99% | 0.53% |
| Feb. 26, 2024 | Thomas John C | Not found | A | Stock Option (right to buy) | 4167 | $0.00 | 4,167.0000 | 751,071 | 9999.99% | 0.55% |